Jane Meza, PhD

Chair Department of Biostatistics

Director, Center for collaboration on research design & analysis
Professor
University of Nebraska Medical Center
College of Public Health

Professional Summary

• 2000 - Present   University of Nebraska College of Medicine
• 2004 - Present   Courtesy Appointment, University of Nebraska-Lincoln, Dept. of Statistics

Education

• PhD  Statistics, University of Nebraska-Lincoln, 2000
• MS   Statistics, University of Nebraska-Lincoln, 1998
• BS    Mathematics, University of Nebraska-Lincoln, 1996

Courses Taught

• PSM 806, Biostatistics I
• PSM 808, Biostatistics II

Research Interest & Projects

My methodological research focuses on statistical issues related to small-area estimation. These methods have been extended to disease mapping applications and combining national and state data to estimate the probability of a rare event.

Selected Publications

• Crist WM, Anderson JR, Meza JL, Fryer C, Raney RB, Ruymann FB, Breneman J, Qualman SJ, Wiener E, Wharam M, Lobe T, Webber B, Maurer HM and Donaldson SS (2001). The Intergroup Rhabdomyosarcoma Study-IV: Results for Patients With Non-Metastatic Disease. Journal of Clinical Oncology , 19 (12): 3091-3102.
• Donaldson SS, Meza J, Breneman J, Crist WM, Laurie F, Qualman S and Wharam M (2001). Results from the IRS-IV Randomized Trial of Hyperfractionated Radiation in Children with Rhabdomyosarcoma - A Report from the IRSG. International Journal of Radiation Biology, Biology and Physics, 51 (3): 718-728.
• Raney B, Meza J, Anderson J, Fryer C, Ortega J, Breneman J, Donaldson SS, Michalski J, Wharam M, Fitzgerald TJ, Qualman S, Sandler E, Wiener E, Gehan E, Maurer H and Crist WM (2002). Treatment of Children and Adolescents with Localized Parameningeal Sarcoma: Experience of the Intergroup Rhabdomyosarcoma Study Group Protocols IRS-II Through -IV, 1978-1997. Medical and Pediatric Oncology , 1: 22-32.
• Pappo AS, Meza JL, Wharam MD, Donaldson SS, Wiener ES, Qualman SJ, Maurer HM and Crist WM (2003). Treatment of Localized Nonorbital, Nonparameningeal Head and Neck Rhabdomyosarcoma: Lessons Learned from Intergroup Rhabdomyosarcoma Studies III and IV. Journal of Clinical Oncology, 21(4):638-645. Meza JL (2003). Empirical Bayes Smoothing of Relative Risks in Disease Mapping. Journal of Statistical Planning and Inference, 112:43-62.
• Michalski JM, Meza J, Breneman JC, Wolden SL, Laurie F, Jodoin M, Raney B, Wharam MD, Donaldson SS (2004). Influence of radiation therapy parameters on outcome in children treated with radiation therapy for localized parameningeal rhabdomyosarcoma in Intergroup Rhabdomyosarcoma Study Group trials II through IV. Int J Radiat Oncol Biol Phys. 15;59(4):1027-38.
• Wharam MD, Meza J, Anderson J, Breneman JC, Donaldson SS, Fitzgerald TJ, Michalski J, Teot LA, Wiener ES, Meyer WH (2004). Failure Pattern and Factors Predictive of Local failure in Rhabdomyosarcoma: A Report of Group III Patients on the Third Intergroup Rhabdomyosarcoma Study. Journal of Clinical Oncology 22(10): 1902-1908.
• Buskirk T and Meza JL (2004). Estimating Lifetime Drug Use Rates with National and State Survey Data. Journal of Official Statistics, 19(3): 237-252.
• Meza JL and Lahiri P (2005). The Cp Statistic Under the Nested Error Regression Model. Survey Methodology 31:105-109.

Professional Affiliations

• Children's Oncology Group